stockrowICU Medical, Inc.
ICUI Healthcare Medical Instruments & Supplies
ICU Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, down 6.33% from fiscal 2024.
- Revenue
- +4.37%
- EPS
- +864.3%
- Free cash flow
- +292.2%
- Total debt
- −12.3%
Quarter to September 2026, against a year earlier
Follow ICUI
Alert me
ICU Medical, Inc. (ICUI) Total debt
ICU Medical, Inc.'s total debt at the end of fiscal 2025 was $1.3B, down 18.8% from $1.6B in fiscal 2024. At the end of the quarter to 30 September 2026 it was $1.2B. Over the past ten years it has ranged from $36.0M (fiscal 2019) to $1.7B (fiscal 2022); the current reading is higher than 57% of that period. ICU Medical, Inc. ranks 13th of 50 Medical Instruments & Supplies companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $1.3B | (18.84%) |
| FY2024 | $1.6B | (2.82%) |
| FY2023 | $1.6B | (1.49%) |
| FY2022 | $1.7B | 3,494.27% |
| FY2021 | $46.0M | (11.54%) |
| FY2020 | $52.0M | 44.44% |
| FY2019 | $36.0M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $1.2B | (6.45%) |
| Jun 2026 | $1.2B | (3.86%) |
| Mar 2026 | $1.3B | (0.32%) |
| Dec 2025 | $1.3B | (2.23%) |
| 27 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| TFX Teleflex Incorporated compare | $2.8B |
| NVST Envista Holdings Corporation compare | $1.4B |
| ICUI ICU Medical, Inc. | $1.2B |
| MMSI Merit Medical Systems, Inc. compare | $737.4M |
| STVN Stevanato Group S.p.A. compare | $545.0M |
| WRBY Warby Parker Inc. compare | $170.2M |
| ATRC AtriCure, Inc. compare | $61.0M |
| PLSE Pulse Biosciences, Inc compare | $9.4M |
| MMED MiniMed Group, Inc. compare | — |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on ICUI
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement